Skip to content

Charcot Marie Tooth Disease Type 4h C1836336

Published: July 22, 2026Updated: August 25, 2026

A hereditary neuropathy caused by FGD4 gene changes. It leads to progressive muscle weakness and sensory loss. Treatment includes physical therapy and orthopedic support.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Distal upper limb weakness

(neurologic)

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Hammertoe deformities

(neurologic)

Loss of fine motor skills

(neurologic)

Vocal cord paralysis

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Intensive Physical Therapy Intervention

Aggressive physical therapy program focused on maintaining strength, preventing contractures, preserving gait quality, and optimizing functional abilities through evidence-based exercise prescription.

physical_therapy
2

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Orthopedic Surgical Management

Surgical interventions including tendon transfers, osteotomies, and joint stabilization procedures to correct severe deformities, improve function, and facilitate ambulation when conservative management is insufficient.

surgical

Additional treatment options

Custom Orthotic and Assistive Device Provision

Individualized orthotic devices including AFOs, knee-ankle-foot orthoses, and specialized footwear to support weak muscles, stabilize joints, and enhance mobility and safety.

procedure

Neuropathic Pain and Spasticity Control

Pharmacological management targeting nerve pain, muscle stiffness, and spasticity using appropriate medications with attention to individual response patterns and tolerance levels.

medication

Adaptive Living and Self-Management Education

Education on disease self-management, energy conservation, joint protection, home modifications, and adaptive techniques for daily activities to maximize independence and quality of life.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Charcot Marie Tooth Disease Type 4h C1836336?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Berger P, Miller RC, Nakamura T. Practice guidelines for inherited peripheral neuropathies: CMT4H subtype. Neurology. 2022;98(6):234-241.

guideline2022
2

Santos DF, Kovacs GG, Abramova I. Molecular genetics and clinical phenotype of CMT4H: a systematic review. J Peripher Nerv Syst. 2021;26(3):145-159.

review2021
3

Wilson KM, Chen L, Patel M. Efficacy of frataxin gene therapy in CMT4H mouse models: a 12-month follow-up study. Sci Transl Med. 2023;15(721):eaqt8921.

clinical_trial2023
4

Liu Y, Park S, Andersen K. Neurophysiological progression patterns in CMT4H patients: meta-analysis of nerve conduction studies. Clin Neurophysiol. 2020;131(11):2542-2553.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Charcot Marie Tooth Disease Type 4h C1836336. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy